Related references
Note: Only part of the references are listed.Not Too Big, Not Too Small: A Goldilocks Approach To Sample Size Selection
Kristine R. Broglio et al.
JOURNAL OF BIOPHARMACEUTICAL STATISTICS (2014)
Prediction of event times in the REMATCH Trial
Gui-Shuang Ying et al.
CLINICAL TRIALS (2013)
Bayesian adaptive trials offer advantages in comparative effectiveness trials: an example in status epilepticus
Jason T. Connor et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2013)
A cardiovascular safety study of LibiGel (testosterone gel) in postmenopausal women with elevated cardiovascular risk and hypoactive sexual desire disordera
William B. White et al.
AMERICAN HEART JOURNAL (2012)
Bayesian clinical trials in action
J. Jack Lee et al.
STATISTICS IN MEDICINE (2012)
Alternatives to the standard Fleming, Harrington, and O'Brien futility boundary
James R. Anderson et al.
CLINICAL TRIALS (2011)
Comparison of Antiarrhythmic Drug Therapy and Radiofrequency Catheter Ablation in Patients With Paroxysmal Atrial Fibrillation A Randomized Controlled Trial
David J. Wilber et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
A predictive probability design for phase II cancer clinical trials
J. Lack Lee et al.
CLINICAL TRIALS (2008)
Novel intraoperative molecular test for sentinel lymph node metastases in patients with early-stage breast cancer
Thomas B. Julian et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Bayesian predictive approach to interim monitoring in clinical trials
A Dmitrienko et al.
STATISTICS IN MEDICINE (2006)
Futility approaches to interim monitoring by data monitoring committees
David L. DeMets
CLINICAL TRIALS (2006)
Bayesian clinical trials
DA Berry
NATURE REVIEWS DRUG DISCOVERY (2006)
Randomized phase II designs in cancer clinical trials: Current status and future directions
JJ Lee et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Bayesian statistics and the efficiency and ethics of clinical trials
DA Berry
STATISTICAL SCIENCE (2004)
A comment on futility monitoring
B Freidlin et al.
CONTROLLED CLINICAL TRIALS (2002)
Bayesian two-stage designs for phase II clinical trials
SB Tan et al.
STATISTICS IN MEDICINE (2002)